HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis

Sultana, Zeeba Zahra; Hoque, Farhana Ul; Beyene, Joseph; Akhlak-Ul-Islam, Md.; Khan, Md Hasinur Rahman; Ahmed, Shakil; Hawlader, Delwer Hossain; Hossain, Ahmed

doi:10.1186/s12879-020-05749-2

BMC Infectious Diseases

Table 1 Characteristics of the included studies in the meta-analysis (according to the order of year)

From: HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis

Author [Ref]	Year	Study design	Study period	Country	Number of TB patients	MDR-TB cases	% of male (MDR-TB cases)	Mean/ Median age (MDR-TB cases), years	TB form	% of EPTB (MDR-TB cases)	MDR-TB type	% of PTC (MDR-TB cases)
Brito et al. [18]	2010	Cross-sectional	2004–2006	Brazil	595	44	72.73	40.1	PTB, EPTB	NA	1^o,2^o	61.36
Andrew et al. [19]	2010	Case-control	2005–2007	South Africa	378	123	50	~ 34	PTB, EPTB	28.63	1^o,2^o	71.75
Sangare et al. [20]	2010	Cross-sectional	2005–2006	Burkina Faso	550	47	NA	NA	PTB	NA	1^o,2^o	81.03
Sangare et al. [21]	2011	Cross-sectional	2005–2006	Burkina Faso	316	42	87.66	NA	NA	NA	1^o,2^o	85.71
Gudo et al. [22]	2011	Cross-sectional	2007–2008	Mozambique	1102	27	61.8	~ 35	PTB	NA	1^o	0
Vadwai et al. [23]	2011	Cross-sectional	2009	India	250	184	61.95	33.06	PTB	NA	1^o,2^o	62.5
Macedo et al. [24]	2012	Cross-sectional	2008–2010	Portugal	2093	50	78	~ 42	PTB, EPTB	8	1^o,2^o	30
Padilla et al. [25]	2012	Cross-sectional	2009–2010	Swaziland	840	122	37.70	~ 33	PTB	NA	1^o,2^o	77.87
van Halsema et al. [26]	2012	Cross-sectional	2002–2008	South Africa	2431	168	NA	NA	NA	NA	1^o,2^o	82.74
Ricks et al. [27]	2012	Case-control	2007–2009	Namibia	368	117	56	36	PTB, EPTB	2	1^o,2^o	97
Tessema et al. [28]	2012	Cross-sectional	2009	Ethiopia	260	13	53.85	NA	PTB	NA	1^o,2^o	61.54
Coelho et al. [29]	2012	Cross-sectional	2000–2004	Brazil	671	32	NA	39.2	PTB	NA	1^o,2^o	68.7
Ulmasova et al. [30]	2013	Cross-sectional	2010–2011	Uzbekistan	1037	372	57.07	~ 45	PTB	NA	1^o,2^o	NA
Minion et al. [31]	2013	Surveillance	1997–2008	Canada	15,993	177	59.35	30	PTB	NA	1^o,2^o	31.10
Sethi et al. [32]	2013	Cross-sectional	2006–2010	India	219	39	66.67	36.6	PTB	NA	1^o,2^o	69.23
Van Den Hof et al. [33]	2013	Cross-sectional	2007–2011	Kazakhstan	146,461	18,338	65.81	NA	PTB, EPTB	1.41	1^o,2^o	85.9
Lukoye et al. [34]	2013	Cross-sectional	2009–2011	Uganda	1537	31	67.74	~ 35	PTB	NA	1^o,2^o	45.16
Hang et al. [35]	2013	Cross-sectional	2007–2009	Vietnam	546	22	NA	38.6	PTB	NA	1^o	0
Skrahina et al. [36]	2013	Cross-sectional	2010–2011	Belarus	1420	612	80	~ 46	PTB	NA	1^o,2^o	75.60
Satti et al. [37]	2013	Cohort	2007–2011	Lesotho	148	47	NA	NA	PTB	NA	2^o	100
Hirpa et al. [38]	2013	Case-control	2011–2012	Ethiopia	268	134	60.50	25.1	PTB, EPTB	3	2^o	100
Mor et al. [39]	2014	Cross-sectional	1999–2010	Israel	3552	207	75.40	43	PTB, EPTB	3.90	2^o	100
Post et al. [40]	2014	Cross-sectional	2004–2006	Belarus, Latvia, Russia, Romania, Ukraine	144	55	74.6	30.2	PTB. EPTB	3.6	1^o,2^o	16.4
Metcalfe et al. [41]	2014	Cross-sectional	2011–2012	Zimbabwe	129	25	52	~ 34	PTB	NA	1^o,2^o	12
Shariff et al. [42]	2015	Case-control	2013–2014	Malaysia	150	30	66.70	51	PTB	NA	1^o,2^o	66.70
Jitmuang et al. [43]	2015	Case-control	2010–2012	Thailand	188	47	57.40	48.9	PTB, EPTB	10.60	1^o,2^o	53.20
Chuchottaworn et al. [44]	2015	Case-control	2007–2013	Thailand	290	145	65.50	46.2	PTB	NA	1^o,2^o	96.60
Elmi et al. [45]	2015	Case-control	2010–2014	Malaysia	314	105	66.70	51	PTB	NA	1^o,2^o	50.50
Mulisa et al. [46]	2015	Case-control	2013–2014	Ethiopia	265	88	56.80	~ 33	PTB	NA	1^o,2^o	90.90
Mulu et al. [47]	2015	Case-control	2013–2014	Ethiopia	306	153	57.50	35	PTB, EPTB	7.80	1^o,2^o	96.10
Gunther et al. [48]	2015	Case-control	2010–2011	23 TBNET sites in 16 countries in Europe	756	380	62.89	~ 36	PTB	NA	1^o,2^o	35
Ershova et al. [49]	2015	Cross-sectional	2012	Russia	229	44	77.30	~ 36	PTB	NA	1^o	0
Abdella et al. [50]	2015	Cross-sectional	2012–2013	Ethiopia	70	22	NA	~ 32	PTB	0	2^o	100
Tadasse [51]	2015	Cross-sectional	2008–2011	Ethiopia	439	113	64.60	29	PTB, EPTB	11.50	1^o,2^o	99.11
Salindri et al. [52]	2016	Cohort	2011–2014	Georgia	318	52	71.15	~ 50	PTB	NA	1^o	0
Lee et al. [53]	2016	Case-control	2006–2014	South Korea	1606		NA	NA	PTB,EPTB	4.5	1^o,2^o	39.85
Assefa et al. [54]	2017	Case-control	2013	Ethiopia	710	229	47.6	31.7	PTB	NA	1^o,2^o	NA
Workicho et al. [55]	2017	Case-control	2011	Ethiopia	180	90	45.60	29.4	PTB	NA	1^o,2^o	91.10
Sinha et al. [56]	2017	Cross-sectional	2012–2014	India	235	124	45.16	35.7	PTB, EPTB	9.68	1^o,2^o	25.80
Mesfin et al. [57]	2018	Cross-sectional	2015–2016	Ethiopia	226	89	41.60	34.4	PTB	NA	1^o,2^o	82
Gobena et al. [58]	2018	Case-control	2016–2017	Ethiopia	132	59	61	30.2	PTB, EPTB	3.40	1^o,2^o	64
Kusumawati et al. [59]	2018	Cross-sectional	2010–2013	Indonesia	842	98	72.40	44.5	PTB	NA	1^o,2^o	64.30
Pavlenko et al. [60]	2018	Cross-sectional	2013–2014	Ukraine	1658	474	75	~ 43	PTB	NA	1^o,2^o	37.92
Desissa et al. [61]	2018	Case-control	2016	Ethiopia	219	73	45.20	32.69	PTB, EPTB	26	1^o,2^o	65.80
Gaborit et al. [62]	2018	Case-control	2002–2013	France	134	44	75	~ 33	PTB, EPTB	36.36	1^o,2^o	52.27
Alene et al. [63]	2019	Case-control	2010–2015	Ethiopia	452	242	60.70	~ 31	PTB, EPTB	6.20	1^o,2^o	93
Baya et al. [64]	2019	Cross-sectional	2007–2016	Mali	214	134	76.12	39.3	PTB	NA	2^o	100
Zurcher et al. [65]	2019	Cross-sectional	2013–2016	Cote d’Ivoire, Demo graphic Republic of the Congo, Kenya, Nigeria, South Africa, Peru, Thailand	871	163	60	33.2	PTB	NA	2^o	100
Okethwangu et al. [66]	2019	Case-control	2013–2017	Uganda	125	33	NA	~ 42	PTB	NA	2^o	100
Fikre et al. [67]	2019	Case-control	2016–2018	Ethiopia	204	102	67.70	35.6	PTB, EPTB	8.80	1^o,2^o	72.50
Elduma et al. [68]	2019	Case-control	2017–2019	Sudan	1290	430	69.77	37.3	PTB	NA	1^o,2^o	67.90
Chan et al. [69]	2020	Surveillance	2011–2016	USA	45,209	615	52.2	~ 45	NA	NA	1^o,2^o	18.04
Arroyo et al. [70]	2020	Cohort	2006–2016	Brazil	167,726	866	70.7	~ 45	PTB, EPTB	3.4	1^o,2^o	54.70
Hirama et al. [71]	2020	Cohort	2010–2016	Canada	402	46	47.8	~ 45	PTB, EPTB	26.08	1^o,2^o	34.80

MDR-TB Multidrug-resistant tuberculosis, PTB Pulmonary tuberculosis, EPTB Extra-pulmonary tuberculosis, PTC Previously treated cases

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com